The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

TNGX FINANCIAL STATEMENTS

Tango Therapeutics Inc — balance sheet, income statement and cash flow trends

TNGXTango Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-100 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue53.8 M $Gross Profit52.9 M $ · 98%Operating Income-136.3 M $ · -253%Pre-tax Income-123.8 M $ · -230%Net Income to Owners-123.7 M $ · -230%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue53.8 M $+121.5%
Gross Profit52.9 M $+123.3%
Operating Income-136.3 M $—
EBITDA-122.3 M $—
Net Income to Owners-123.7 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M1 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets1.1 B
  • Equity1 B $95%
  • Current Liabilities20.3 M $2%
  • Long-term Liabilities29 M $3%

Key Figures

YoY change
Total Assets1.1 B $+351.4%
Total Liabilities49.3 M $-52.1%
Total Equity1 B $+659.2%
Cash & ST Investments1 B $+460.9%
Total Debt32 M $-8.6%
Net Debt-313.6 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-100 M0100 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-500 M0-143.9 M $Operating-524.6 M $Investing974.3 M $Financing305.9 M $Net Change

Key Figures

YoY change
Operating Cash Flow-143.9 M $—
Capital Expenditures375 K $-59.0%
Free Cash Flow-144.3 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on TNGX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.